2011
DOI: 10.1089/thy.2010.0159
|View full text |Cite
|
Sign up to set email alerts
|

Management of Severe Thyrotoxicosis When the Gastrointestinal Tract Is Compromised

Abstract: Although a rare scenario, the management of patients with severe thyrotoxicosis in the absence of a functional gastrointestinal tract represents a challenging clinical situation. Endocrinologists and critical care physicians should be apprised of the available treatment modalities which must be instituted swiftly in order to avoid a catastrophic outcome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(12 citation statements)
references
References 40 publications
0
10
0
1
Order By: Relevance
“…She became euthyroid with methimazole and her thyroxine levels decreased further when she underwent plasmapheresis despite being off antithyroid medications. Plasmapheresis has been used as a temporary measure to decrease thyroid hormone levels in patients who cannot tolerate traditional therapy 13 14Learning points

Although hyperthyroidism is associated with neuropsychiatric symptoms, persistence of symptoms despite normalisation of thyroid levels should prompt further evaluation for another cause.

Anti-N-methyl-D-aspartate receptor and Graves’ disease are both autoimmune disorders that may have a shared mechanism of pathophysiology, as suggested by our case.

…”
Section: Discussionmentioning
confidence: 85%
“…She became euthyroid with methimazole and her thyroxine levels decreased further when she underwent plasmapheresis despite being off antithyroid medications. Plasmapheresis has been used as a temporary measure to decrease thyroid hormone levels in patients who cannot tolerate traditional therapy 13 14Learning points

Although hyperthyroidism is associated with neuropsychiatric symptoms, persistence of symptoms despite normalisation of thyroid levels should prompt further evaluation for another cause.

Anti-N-methyl-D-aspartate receptor and Graves’ disease are both autoimmune disorders that may have a shared mechanism of pathophysiology, as suggested by our case.

…”
Section: Discussionmentioning
confidence: 85%
“…Treatment of thyrotoxicosis was further complicated by vomiting, which could have been caused by both hypercalcaemia and thyrotoxicosis. Rectal, sublingual and intravenous preparations of both PTU and inorganic iodine have been compounded and used successfully in a few cases [15]. However, parenteral formulations of inorganic iodine or PTU are not commercially available in the Netherlands.…”
Section: Discussionmentioning
confidence: 99%
“…Ввиду от-сутствия стерильных форм препаратов йода ранее применявшееся медленное внутривенное введение йодида натрия (NaI) в настоящее время недоступно. Описаны как ректальный, так и сублингвальный способы введения данных препаратов [11,20].…”
Section: лечениеunclassified